Phase I trial of oral talactoferrin alfa in refractory solid tumors

By Hayes Teresa   Falchook Gerald   Varadhachary Gauri   Smith Dori   Davis Lisa   Dhingra Hari   Hayes Benjamin   Varadhachary Atul  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 233-240

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of vinflunine and pemetrexed in refractory solid tumors

By Sanoff Hanna   Davies Janine   Walko Christine   Buie Larry   Chiu Wing-Keung   Ivanova Anastasia   O’Neil Bert   Stinchcombe Thomas   Keller Kimberly   Dees E.  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors

By Feldman Darren   Turkula Stefan   Ginsberg Michelle   Ishill Nicole   Patil Sujata   Carousso Maryann   Bosl George   Motzer Robert  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 523-528

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors

By Varuni Kondagunta G.   Bacik Jennifer   Schwartz Lawrence   Sheinfeld Joel   Bajorin Dean   Vuky Jacqueline   Marion Stephanie   Mazumdar Madhu   Bosl George J.   Motzer Robert J.  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 177-179

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite